Format

Send to

Choose Destination
JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.

Author information

1
Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland.
2
Section of General Internal Medicine, Veterans Affairs Medical Center, Portland, Oregon.
3
Center for Health Care Ethics, Oregon Health and Science University, Portland.
PMID:
29800087
DOI:
10.1001/jama.2018.5330
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center